Brain metastases for Her2 positive breast cancer patients: a systematic review (on the behalf of Italian Association of Radiotherapy and Clinical Oncology)
{{output}}
Brain metastases (BMs) are prevalent among patients diagnosed with human epidermal growth factor receptor 2 (HER2)positive metastatic breast cancer (BC), with the incidence rate exceeding 30%. The management of BMs typically involves multiple approaches, such ... ...
